Zhenzhou N. Jiang

State Key Laboratory Of Natural Medicines
Nanjing, 210009, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 191 publications

Preventive effects of Agrocybe chaxingu extracts on ovariectomy-induced osteoporosis in rats via gut microbiota modulation.

Preventive effects of Agrocybe chaxingu extracts on ovariectomy-induced osteoporosis in rats via gut microbiota modulation.

Journal: Food & function

Published: August 28, 2026

Reprogramming Acetaminophen Metabolism via Amide-to-Thioamide Modification to Prevent Drug-Induced Liver Injury.

Reprogramming Acetaminophen Metabolism via Amide-to-Thioamide Modification to Prevent Drug-Induced Liver Injury.

Journal: Journal of medicinal chemistry

Published: July 01, 2026

A highly sensitive LC-MS/MS method for quantification of AB-38b in rat plasma, liver and kidney tissues: application to a pharmacokinetic study.

A highly sensitive LC-MS/MS method for quantification of AB-38b in rat plasma, liver and kidney tissues: application to a pharmacokinetic study.

Journal: Analytical methods : advancing methods and applications

Published: January 12, 2026

Analysis of risk factors for herb-induced liver injury: a retrospective study from China.

Analysis of risk factors for herb-induced liver injury: a retrospective study from China.

Journal: Frontiers in pharmacology

Published: December 12, 2025

Unveiling a novel macrophage-driven mechanism for obeticholic acid-induced liver injury in cholestatic: targeting NLRP12Arg185 fuels Relb-TNFSF14-mediated ductular reaction.

Unveiling a novel macrophage-driven mechanism for obeticholic acid-induced liver injury in cholestatic: targeting NLRP12Arg185 fuels Relb-TNFSF14-mediated ductular reaction.

Journal: Cell biology and toxicology

Published: December 07, 2025

Fenofibrate anti-RARα/RXRα dimerization to attenuate all-trans retinoic acid-induced hyperlipidemia and hepatic steatosis in mice.

Fenofibrate anti-RARα/RXRα dimerization to attenuate all-trans retinoic acid-induced hyperlipidemia and hepatic steatosis in mice.

Journal: Cellular signalling

Published: November 17, 2025

Targeting cholangiocyte sphingosine-1-phosphate (S1P) receptor 1 signaling alleviates cholestatic liver injury: Mechanistic insight into S1P/phosphorylated signal transducer and activator of transcription 3 axis.

Targeting cholangiocyte sphingosine-1-phosphate (S1P) receptor 1 signaling alleviates cholestatic liver injury: Mechanistic insight into S1P/phosphorylated signal transducer and activator of transcription 3 axis.

Journal: The Journal of pharmacology and experimental therapeutics

Published: October 18, 2025

Predictive serum metabolic markers in GDM patients: A targeted metabolomics study combined with machine learning of sex steroid hormones.

Predictive serum metabolic markers in GDM patients: A targeted metabolomics study combined with machine learning of sex steroid hormones.

Journal: Journal of pharmaceutical analysis

Published: July 25, 2025

Jujuboside A ameliorates glomerular podocytes lipotoxicity in diabetic mice by YY1-mediated promotion of intracellular cholesterol transport and efflux.

Jujuboside A ameliorates glomerular podocytes lipotoxicity in diabetic mice by YY1-mediated promotion of intracellular cholesterol transport and efflux.

Journal: The Journal of nutritional biochemistry

Published: July 16, 2025

PTBP1 inhibition reprograms myogenesis to rescue impaired muscle regeneration in mdx mice through correcting E2A splicing.

PTBP1 inhibition reprograms myogenesis to rescue impaired muscle regeneration in mdx mice through correcting E2A splicing.

Journal: Nature communications

Published: May 27, 2025

Obeticholic acid exacerbates liver injury through hepatocyte-mediated release of HMGB1 by inducing lysosomal membrane permeabilization in cholestasis.

Obeticholic acid exacerbates liver injury through hepatocyte-mediated release of HMGB1 by inducing lysosomal membrane permeabilization in cholestasis.

Journal: Chemico-biological interactions

Published: May 22, 2025

Leflunomide-inhibited STAT1 activity ameliorates intramuscular M1 macrophage infiltration and promotes muscle regeneration in Duchenne muscular dystrophy.

Leflunomide-inhibited STAT1 activity ameliorates intramuscular M1 macrophage infiltration and promotes muscle regeneration in Duchenne muscular dystrophy.

Journal: British journal of pharmacology

Published: April 24, 2025

Showing 1-12 of 191

Last Updated: 09/26/2026